Skip Navigation

European Heart Journal 1989 10(Supplement H):85-91; doi:10.1093/eurheartj/10.suppl_H.85
Copyright © 1989 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Dimas, A. P.
Right arrow Articles by Healy, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dimas, A. P.
Right arrow Articles by Healy, B.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1989 The European Society of Cardiology

Coronary artery bypass surgery vs coronary angioplasty: from antithesis to synthesis

A. P. Dimas and B. Healy

The Research Institute and the Department of Cardiology, The Cleveland Clinic Foundation Cleveland, Ohio, U.S.A.

Address correspondence to: Bernadine Healy, M.D., Chairman, Research Institute, The Cleveland Clinic Foundation, One Clinic Center, 9500 Euclid Avenue, Cleveland, Ohio 44195–5210, U.S.A.

Over the last two decades, revascularization therapy has greatly improved the management of patients with coronary artery disease. Coronary artery bypass graft (CABG) surgery has been proven by several randomized trials to alleviate symptoms, prevent myocardial infarction, and prolong survival in patients with moderately severe disease. Percutaneous transluminal coronary angioplasty (PTCA) has emerged as an alternative treatment for an increasing number of these patients. The use of coronary angioplasty has been expanding rapidly to include single-vessel and multivessel disease and acute ischaemic syndromes. Although the angiographic success rate in properly selected cases exceeds 90%, there are limited data regarding the long-term results with angioplasty in the treatment of patients with multivessel disease. Procedure-related mortality and restenosis rate remain major areas of concern.

Several randomized clinical trials (CABRI, RITA, GABI, EAST, BARl) currently in progress are comparing PTCA and CABG in the management of patients with multivessel coronary artery disease. It is anticipated that these studies will provide a wealth of information, enabling physicians to construct a revascularization strategy that will maximally benefit their patients.

Key Words: Coronary angioplasty • coronary bypass graft surgery • multivessel coronary disease • clinical trials


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 ANN INTERN MEDHome page
J. B. Wong, F. A. Sonnenberg, D. N. Salem, and S. G. Pauker
Myocardial Revascularization for Chronic Stable Angina: Analysis of the Role of Percutaneous Transluminal Coronary Angioplasty Based on Data Available in 1989
Ann Intern Med, December 1, 1990; 113(11): 852 - 871.
[Abstract] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.